SitePoint Sponsor

User Tag List

Results 1 to 6 of 6
  1. #1
    SitePoint Guru ripcurlksm's Avatar
    Join Date
    Aug 2004
    Location
    San Clemente, CA
    Posts
    859
    Mentioned
    0 Post(s)
    Tagged
    0 Thread(s)

    (Go Daddy) Setting up reverse DNS lookup and A Name records for better email delivery

    Is anyone able to audit my A Name records and Reverse DNS lookup to see if my records are optimized to have the best email results to clients? I've read in a few articles that if you are having problems getting to some peoples inbox, setting up a few things with the domain can help. Is this true?

    My domain is: <snip />
    Last edited by DaveMaxwell; Dec 13, 2012 at 11:56. Reason: removed URL per OP request....

  2. #2
    SitePoint Enthusiast PromptSpace's Avatar
    Join Date
    Jun 2012
    Posts
    96
    Mentioned
    1 Post(s)
    Tagged
    0 Thread(s)
    Your DNS Setup looks to be fine to me. Make sure your IP is not blacklisted.
    Host4Geeks | Hosting powered by geeks, enhanced with a scoop of
    love and awesomeness!!

    The goal as a company is to have customer service that's not
    just great, but legendary -Henry Ford

  3. #3
    SitePoint Guru ripcurlksm's Avatar
    Join Date
    Aug 2004
    Location
    San Clemente, CA
    Posts
    859
    Mentioned
    0 Post(s)
    Tagged
    0 Thread(s)
    Quote Originally Posted by PromptSpace View Post
    Your DNS Setup looks to be fine to me. Make sure your IP is not blacklisted.
    I'm not blacklisted. I've read articles that talks about reverse DNS lookup, where it lists your ip address and domain name.

  4. #4
    Foozle Reducer ServerStorm's Avatar
    Join Date
    Feb 2005
    Location
    Burlington, Canada
    Posts
    2,699
    Mentioned
    89 Post(s)
    Tagged
    6 Thread(s)
    Quote Originally Posted by ripcurlksm View Post
    I'm not blacklisted. I've read articles that talks about reverse DNS lookup, where it lists your ip address and domain name.
    This is what your reverse DNS reports currently (using http://mxtoolbox.com):
    Code:
    Test Result
    SMTP Reverse Banner Check OK - 64.131.82.144 resolves to vps.lifescienceintelligence.com
    SMTP Reverse DNS Mismatch OK - Reverse DNS matches SMTP Banner
    SMTP TLS OK - Supports TLS.
    SMTP Connection Time 0 seconds - Good on Connection time
    SMTP Open Relay OK - Not an open relay.
    SMTP Transaction Time 4.649 seconds - Good on Transaction Time
    Session Transcript: EHLO please-read-policy.mxtoolbox.com 250-vps.lifescienceintelligence.com Hello mxtb-pws3.mxtoolbox.com [64.20.227.133] 250-SIZE 52428800 250-8BITMIME 250-PIPELINING 250-AUTH PLAIN LOGIN 250-STARTTLS 250 HELP [47 ms] MAIL FROM: <supertool@mxtoolbox.com> 250 OK [47 ms] RCPT TO: <test@example.com> 550-Please turn on SMTP Authentication in your mail client, or login to the 550-IMAP/POP3 server before sending your message. mxtb-pws3.mxtoolbox.com 550-(please-read-policy.mxtoolbox.com) [64.20.227.133]:50707 is not permitted 550 to relay through this server without authentication. [4368 ms] QUIT 221 vps.lifescienceintelligence.com closing connection [47 ms]
    So you do have your reverse DNS set-up correctly.

    There can be many different reasons for mail not performing well. How busy is your overall VPS; can you map the performance on email when database queries are occurring as well as overall site traffic? Is your server fast enough to host and deal with your site traffic plus the email server? How much mail do you send and how frequently? Does your site have significant latency in areas where you send email? Have you checked if the mail you send is rfc compliant; some severs may reject your mail if it does not comply?

    Steve
    ictus==""

  5. #5
    SitePoint Guru ripcurlksm's Avatar
    Join Date
    Aug 2004
    Location
    San Clemente, CA
    Posts
    859
    Mentioned
    0 Post(s)
    Tagged
    0 Thread(s)
    Steve, thank you for taking the time to check out my site. All this is being prompted from a co-worker that we are using as a test case for marketing. They have their junk email filter set to "High".

    If we send them a message from Outlook with a subject line it goes to the Inbox and the "view source" of the email looks like this:
    Code:
    <html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40"><head><META HTTP-EQUIV="Content-Type" CONTENT="text/html; charset=us-ascii"><meta name=Generator content="Microsoft Word 12 (filtered medium)"><!--[if !mso]><style>v\:* {behavior:url(#default#VML);}
    o\:* {behavior:url(#default#VML);}
    w\:* {behavior:url(#default#VML);}
    .shape {behavior:url(#default#VML);}
    </style><![endif]--><style><!--
    /* Font Definitions */
    @font-face
    	{font-family:"Cambria Math";
    	panose-1:2 4 5 3 5 4 6 3 2 4;}
    @font-face
    	{font-family:Calibri;
    	panose-1:2 15 5 2 2 2 4 3 2 4;}
    @font-face
    	{font-family:Tahoma;
    	panose-1:2 11 6 4 3 5 4 4 2 4;}
    /* Style Definitions */
    p.MsoNormal, li.MsoNormal, div.MsoNormal
    	{margin:0in;
    	margin-bottom:.0001pt;
    	font-size:11.0pt;
    	font-family:"Calibri","sans-serif";}
    a:link, span.MsoHyperlink
    	{mso-style-priority:99;
    	color:blue;
    	text-decoration:underline;}
    a:visited, span.MsoHyperlinkFollowed
    	{mso-style-priority:99;
    	color:purple;
    	text-decoration:underline;}
    p
    	{mso-style-priority:99;
    	mso-margin-top-alt:auto;
    	margin-right:0in;
    	mso-margin-bottom-alt:auto;
    	margin-left:0in;
    	font-size:12.0pt;
    	font-family:"Times New Roman","serif";}
    p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
    	{mso-style-priority:99;
    	mso-style-link:"Balloon Text Char";
    	margin:0in;
    	margin-bottom:.0001pt;
    	font-size:8.0pt;
    	font-family:"Tahoma","sans-serif";}
    p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph
    	{mso-style-priority:34;
    	margin-top:0in;
    	margin-right:0in;
    	margin-bottom:0in;
    	margin-left:.5in;
    	margin-bottom:.0001pt;
    	font-size:11.0pt;
    	font-family:"Calibri","sans-serif";}
    span.EmailStyle17
    	{mso-style-type:personal-compose;
    	font-family:"Calibri","sans-serif";
    	color:windowtext;}
    span.apple-converted-space
    	{mso-style-name:apple-converted-space;}
    span.BalloonTextChar
    	{mso-style-name:"Balloon Text Char";
    	mso-style-priority:99;
    	mso-style-link:"Balloon Text";
    	font-family:"Tahoma","sans-serif";}
    .MsoChpDefault
    	{mso-style-type:export-only;}
    @page WordSection1
    	{size:8.5in 11.0in;
    	margin:1.0in 1.0in 1.0in 1.0in;}
    div.WordSection1
    	{page:WordSection1;}
    /* List Definitions */
    @list l0
    	{mso-list-id:496192127;
    	mso-list-type:hybrid;
    	mso-list-template-ids:1887317496 67698689 67698691 67698693 67698689 67698691 67698693 67698689 67698691 67698693;}
    @list l0:level1
    	{mso-level-number-format:bullet;
    	mso-level-text:\F0B7;
    	mso-level-tab-stop:none;
    	mso-level-number-position:left;
    	text-indent:-.25in;
    	font-family:Symbol;}
    @list l0:level2
    	{mso-level-tab-stop:1.0in;
    	mso-level-number-position:left;
    	text-indent:-.25in;}
    @list l0:level3
    	{mso-level-tab-stop:1.5in;
    	mso-level-number-position:left;
    	text-indent:-.25in;}
    @list l0:level4
    	{mso-level-tab-stop:2.0in;
    	mso-level-number-position:left;
    	text-indent:-.25in;}
    @list l0:level5
    	{mso-level-tab-stop:2.5in;
    	mso-level-number-position:left;
    	text-indent:-.25in;}
    @list l0:level6
    	{mso-level-tab-stop:3.0in;
    	mso-level-number-position:left;
    	text-indent:-.25in;}
    @list l0:level7
    	{mso-level-tab-stop:3.5in;
    	mso-level-number-position:left;
    	text-indent:-.25in;}
    @list l0:level8
    	{mso-level-tab-stop:4.0in;
    	mso-level-number-position:left;
    	text-indent:-.25in;}
    @list l0:level9
    	{mso-level-tab-stop:4.5in;
    	mso-level-number-position:left;
    	text-indent:-.25in;}
    @list l1
    	{mso-list-id:2097897314;
    	mso-list-type:hybrid;
    	mso-list-template-ids:-168770404 67698689 67698691 67698693 67698689 67698691 67698693 67698689 67698691 67698693;}
    @list l1:level1
    	{mso-level-number-format:bullet;
    	mso-level-text:\F0B7;
    	mso-level-tab-stop:none;
    	mso-level-number-position:left;
    	text-indent:-.25in;
    	font-family:Symbol;}
    @list l1:level2
    	{mso-level-tab-stop:1.0in;
    	mso-level-number-position:left;
    	text-indent:-.25in;}
    @list l1:level3
    	{mso-level-tab-stop:1.5in;
    	mso-level-number-position:left;
    	text-indent:-.25in;}
    @list l1:level4
    	{mso-level-tab-stop:2.0in;
    	mso-level-number-position:left;
    	text-indent:-.25in;}
    @list l1:level5
    	{mso-level-tab-stop:2.5in;
    	mso-level-number-position:left;
    	text-indent:-.25in;}
    @list l1:level6
    	{mso-level-tab-stop:3.0in;
    	mso-level-number-position:left;
    	text-indent:-.25in;}
    @list l1:level7
    	{mso-level-tab-stop:3.5in;
    	mso-level-number-position:left;
    	text-indent:-.25in;}
    @list l1:level8
    	{mso-level-tab-stop:4.0in;
    	mso-level-number-position:left;
    	text-indent:-.25in;}
    @list l1:level9
    	{mso-level-tab-stop:4.5in;
    	mso-level-number-position:left;
    	text-indent:-.25in;}
    ol
    	{margin-bottom:0in;}
    ul
    	{margin-bottom:0in;}
    --></style><!--[if gte mso 9]><xml>
    <o:shapedefaults v:ext="edit" spidmax="2050" />
    </xml><![endif]--><!--[if gte mso 9]><xml>
    <o:shapelayout v:ext="edit">
    <o:idmap v:ext="edit" data="1" />
    </o:shapelayout></xml><![endif]--></head><body lang=EN-US link=blue vlink=purple><div class=WordSection1><p class=MsoNormal><o:p>&nbsp;</o:p></p><p class=MsoNormal><img width=264 height=67 id="Picture_x0020_1" src="cid:image001.gif@01CDBB50.A40B3C70" alt="cid:image001.gif@01CDA7BC.8946A110"><o:p></o:p></p><p class=MsoNormal><o:p>&nbsp;</o:p></p><p class=MsoNormal>Bernadette,<o:p></o:p></p><p class=MsoNormal><o:p>&nbsp;</o:p></p><p style='margin:0in;margin-bottom:.0001pt'><span style='font-size:11.0pt;font-family:"Calibri","sans-serif"'>Current and hopeful competitors selling medical products in Mexico will benefit from <b>a complete roadmap and essential data</b> as provided in our newest report:<span style='color:black'> </span>&nbsp;Medical Device Market Opportunities in Mexico, 2012.<o:p></o:p></span></p><p style='margin:0in;margin-bottom:.0001pt'><span style='font-size:11.0pt;font-family:"Calibri","sans-serif"'><o:p>&nbsp;</o:p></span></p><p style='margin:0in;margin-bottom:.0001pt'><span style='font-size:11.0pt;font-family:"Calibri","sans-serif"'><a href="http://www.lifescienceintelligence.com/click/click.php?p=market-creports-page.php?id=LSI-OUS124SU&amp;e=bsilva@lifescienceintelligence.com&amp;i=1&amp;n=Bernadette">Medical Device Market Opportunities in Mexico, 2012</a>, from our extensive <a href="http://lifescienceintelligence.com/click/click.php?p=market-reports-index.php&amp;e=bsilva@lifescienceintelligence.com&amp;i=1&amp;n=Bernadette">Library of Reports</a>, quantifies, analyzes, and forecasts the trends and opportunities in the medical devices market in Mexico.<span style='color:black'> </span>&nbsp;Historical data covers 2007-2010; the most recent actual year data is for 2011; and forecasts extend through 2014.<o:p></o:p></span></p><p style='margin:0in;margin-bottom:.0001pt'><strong><o:p>&nbsp;</o:p></strong></p><p class=MsoNormal><b>Questions Answered in This Report:</b><o:p></o:p></p><p class=MsoListParagraph style='text-indent:-.25in;mso-list:l1 level1 lfo1'><![if !supportLists]><span style='font-family:Symbol'><span style='mso-list:Ignore'>&middot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><![endif]>What are the key population, economic and healthcare data and trends that a medical device manufacturer needs to know to be competitive in Mexico?<o:p></o:p></p><p class=MsoListParagraph style='text-indent:-.25in;mso-list:l1 level1 lfo1'><![if !supportLists]><span style='font-family:Symbol'><span style='mso-list:Ignore'>&middot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><![endif]>What are the disease incidence &amp; prevalence data? What are the future trends? What do current and emerging patient caseloads look like? Where are the opportunities?<o:p></o:p></p><p class=MsoListParagraph style='text-indent:-.25in;mso-list:l1 level1 lfo1'><![if !supportLists]><span style='font-family:Symbol'><span style='mso-list:Ignore'>&middot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><![endif]>Procedure volumes and growth differ dramatically within the different therapeutic areas in Mexico. What is the volume of surgical procedures currently being performed in each therapeutic area? What are the growth trends? Where are the procedures being performed?<o:p></o:p></p><p class=MsoListParagraph style='text-indent:-.25in;mso-list:l1 level1 lfo1'><![if !supportLists]><span style='font-family:Symbol'><span style='mso-list:Ignore'>&middot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><![endif]>What is the regulatory path for getting a medical device approved in Mexico? What other market barriers or challenges exist?<o:p></o:p></p><p class=MsoListParagraph style='text-indent:-.25in;mso-list:l1 level1 lfo1'><![if !supportLists]><span style='font-family:Symbol'><span style='mso-list:Ignore'>&middot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><![endif]>How does a medical product company access this market? What are the sales models -- distributor, direct sales force, hybrid, other?<o:p></o:p></p><p class=MsoListParagraph style='text-indent:-.25in;mso-list:l1 level1 lfo1'><![if !supportLists]><span style='font-family:Symbol'><span style='mso-list:Ignore'>&middot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><![endif]>What other challenges and opportunities exist in Mexico for current and hopeful market participants?<o:p></o:p></p><p class=MsoNormal><o:p>&nbsp;</o:p></p><p class=MsoNormal><b>Essential Data:<o:p></o:p></b></p><p class=MsoListParagraph style='text-indent:-.25in;mso-list:l0 level1 lfo2'><![if !supportLists]><span style='font-family:Symbol'><span style='mso-list:Ignore'>&middot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><![endif]>Key Population Data, Trends, Indicators <o:p></o:p></p><p class=MsoListParagraph style='text-indent:-.25in;mso-list:l0 level1 lfo2'><![if !supportLists]><span style='font-family:Symbol'><span style='mso-list:Ignore'>&middot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><![endif]>Key Economic Data, Trends, Indicators <o:p></o:p></p><p class=MsoListParagraph style='text-indent:-.25in;mso-list:l0 level1 lfo2'><![if !supportLists]><span style='font-family:Symbol'><span style='mso-list:Ignore'>&middot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><![endif]>Key Healthcare Data, Trends, Indicators <o:p></o:p></p><p class=MsoListParagraph style='text-indent:-.25in;mso-list:l0 level1 lfo2'><![if !supportLists]><span style='font-family:Symbol'><span style='mso-list:Ignore'>&middot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><![endif]>Clinical Indicators &amp; Statistics, by Segment <o:p></o:p></p><p class=MsoListParagraph style='text-indent:-.25in;mso-list:l0 level1 lfo2'><![if !supportLists]><span style='font-family:Symbol'><span style='mso-list:Ignore'>&middot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><![endif]>Disease Incidence &amp; Prevalence Statistics, by Segment <o:p></o:p></p><p class=MsoListParagraph style='text-indent:-.25in;mso-list:l0 level1 lfo2'><![if !supportLists]><span style='font-family:Symbol'><span style='mso-list:Ignore'>&middot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><![endif]>Barriers to Entry for Medical Product Companies<o:p></o:p></p><p class=MsoListParagraph style='text-indent:-.25in;mso-list:l0 level1 lfo2'><![if !supportLists]><span style='font-family:Symbol'><span style='mso-list:Ignore'>&middot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><![endif]>Regulatory Overview, Challenges and Path<o:p></o:p></p><p class=MsoListParagraph style='text-indent:-.25in;mso-list:l0 level1 lfo2'><![if !supportLists]><span style='font-family:Symbol'><span style='mso-list:Ignore'>&middot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><![endif]>Channel Analysis &amp; Potential Sales Models (Distributor, Direct, Hybrid, Other)<o:p></o:p></p><p class=MsoListParagraph style='text-indent:-.25in;mso-list:l0 level1 lfo2'><![if !supportLists]><span style='font-family:Symbol'><span style='mso-list:Ignore'>&middot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><![endif]>Emerging Trends, Opportunities, and Market Outlook <o:p></o:p></p><p class=MsoListParagraph style='text-indent:-.25in;mso-list:l0 level1 lfo2'><![if !supportLists]><span style='font-family:Symbol'><span style='mso-list:Ignore'>&middot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><![endif]>Surgical Procedure Volumes, by Segment <o:p></o:p></p><p class=MsoNormal><o:p>&nbsp;</o:p></p><p class=MsoNormal>Additional Opportunity Reports are available:<span style='color:black'> </span>&nbsp;<span style='color:blue'><a href="http://lifescienceintelligence.com/click/click.php?p=market-creports-page.php?id=LSI-OUS121SU&amp;e=bsilva@lifescienceintelligence.com&amp;i=1&amp;n=Bernadette"><span style='text-decoration:none'>Brazil</span></a></span><span style='color:black;background:white'>,<span class=apple-converted-space> </span></span><span style='color:blue'><a href="http://lifescienceintelligence.com/click/click.php?p=market-creports-page.php?id=LSI-OUS125SU&amp;e=bsilva@lifescienceintelligence.com&amp;i=1&amp;n=Bernadette"><span style='text-decoration:none'>Russia</span></a></span><span style='color:black;background:white'>,<span class=apple-converted-space> </span></span><span style='color:blue'><a href="http://lifescienceintelligence.com/click/click.php?p=market-creports-page.php?id=LSI-OUS122SU&amp;e=bsilva@lifescienceintelligence.com&amp;i=1&amp;n=Bernadette"><span style='text-decoration:none'>India</span></a></span><span style='color:black;background:white'>,<span class=apple-converted-space> </span></span><span style='color:blue'><a href="http://lifescienceintelligence.com/click/click.php?p=market-creports-page.php?id=LSI-OUS123SU&amp;e=bsilva@lifescienceintelligence.com&amp;i=1&amp;n=Bernadette"><span style='text-decoration:none'>China</span></a></span><span style='color:black;background:white'>,<span class=apple-converted-space> </span></span><span style='color:blue'><a href="http://lifescienceintelligence.com/click/click.php?p=market-creports-page.php?id=LSI-OUS126SU&amp;e=bsilva@lifescienceintelligence.com&amp;i=1&amp;n=Bernadette"><span style='text-decoration:none'>France</span></a></span><span style='color:black;background:white'>,<span class=apple-converted-space> </span></span><span style='color:blue'><a href="http://lifescienceintelligence.com/click/click.php?p=market-creports-page.php?id=LSI-OUS127SU&amp;e=bsilva@lifescienceintelligence.com&amp;i=1&amp;n=Bernadette"><span style='text-decoration:none'>Germany</span></a></span><span style='color:black;background:white'>,<span class=apple-converted-space> </span></span><span style='color:blue'><a href="http://lifescienceintelligence.com/click/click.php?p=market-creports-page.php?id=LSI-OUS128SU&amp;e=bsilva@lifescienceintelligence.com&amp;i=1&amp;n=Bernadette"><span style='text-decoration:none'>Italy</span></a></span><span style='color:black;background:white'>, the<span class=apple-converted-space> </span></span><span style='color:blue'><a href="http://lifescienceintelligence.com/click/click.php?p=market-creports-page.php?id=LSI-OUS129SU&amp;e=bsilva@lifescienceintelligence.com&amp;i=1&amp;n=Bernadette"><span style='text-decoration:none'>United Kingdom</span></a></span><span style='color:black;background:white'>, and<span class=apple-converted-space> </span></span><span style='color:blue'><a href="http://lifescienceintelligence.com/click/click.php?p=market-creports-page.php?id=LSI-OUS1210SU&amp;e=bsilva@lifescienceintelligence.com&amp;i=1&amp;n=Bernadette"><span style='text-decoration:none'>Spain</span></a></span>.<o:p></o:p></p><p class=MsoNormal><span style='color:black'><o:p>&nbsp;</o:p></span></p><p class=MsoNormal><span style='color:black'>If you have any questions or would like to place an order, feel free to order online, reply to this e-mail, or give me a call.<o:p></o:p></span></p><p class=MsoNormal><span style='color:black'><o:p>&nbsp;</o:p></span></p><p class=MsoNormal>Regards,<span style='color:black'> <o:p></o:p></span></p><p class=MsoNormal><span style='color:black'><o:p>&nbsp;</o:p></span></p><p class=MsoNormal><span style='color:black'>Brad<o:p></o:p></span></p><p class=MsoNormal><span style='color:black'><o:p>&nbsp;</o:p></span></p><p class=MsoNormal><span style='color:black'>Brad Shwam<o:p></o:p></span></p><p class=MsoNormal><span style='color:black'>Director of Sales<o:p></o:p></span></p><p class=MsoNormal><span style='color:black'>Life Science Intelligence (LSI)<o:p></o:p></span></p><p class=MsoNormal><span style='color:black'>Tel: &nbsp;1-714-847-3540, ext. 26<o:p></o:p></span></p><p class=MsoNormal><span style='color:black'><a href="mailto:brad@LifeScienceIntelligence.com">brad@LifeScienceIntelligence.com</a><o:p></o:p></span></p><p class=MsoNormal><span style='color:blue'><a href="http://www.lifescienceintelligence.com/">www.LifeScienceIntelligence.com</a><o:p></o:p></span></p><p class=MsoNormal><span style='color:blue'><o:p>&nbsp;</o:p></span></p><p style='margin:0in;margin-bottom:.0001pt'><span style='font-size:11.0pt;font-family:"Calibri","sans-serif";color:black'>To ensure delivery of our updates to your inbox, please add @LifeScienceIntelligence.com to your address book, contact list, or Safe Senders list.<o:p></o:p></span></p><p style='margin:0in;margin-bottom:.0001pt'><span style='font-size:11.0pt;font-family:"Calibri","sans-serif";color:black'><o:p>&nbsp;</o:p></span></p><p style='margin:0in;margin-bottom:.0001pt'><span style='font-size:11.0pt;font-family:"Calibri","sans-serif";color:black'>If you do not want to receive these updates from us, simply reply with &quot;REMOVE&quot; in the subject line.<o:p></o:p></span></p><p class=MsoNormal><span style='color:black'><o:p>&nbsp;</o:p></span></p><p class=MsoNormal><span style='color:black'>&copy; Copyright 2012 by Life Science Intelligence. &nbsp;All rights reserved.<o:p></o:p></span></p><p class=MsoNormal><span style='color:black'><o:p>&nbsp;</o:p></span></p><p style='margin:0in;margin-bottom:.0001pt'><span style='font-size:11.0pt;font-family:"Calibri","sans-serif";color:black'>Life Science Intelligence (LSI)</span><span style='font-size:11.0pt;font-family:"Calibri","sans-serif"'><o:p></o:p></span></p><p class=MsoNormal><span style='color:black'>7372 Prince Drive, Suite 208</span><o:p></o:p></p><p class=MsoNormal><span style='color:black'>Huntington Beach, CA 92647<o:p></o:p></span></p><p class=MsoNormal><span style='color:black'>USA</span><o:p></o:p></p><p class=MsoNormal><span style='color:black'>Tel: 1-714-847-3540<o:p></o:p></span></p><p class=MsoNormal><o:p>&nbsp;</o:p></p><p class=MsoNormal><o:p>&nbsp;</o:p></p><p class=MsoNormal><o:p>&nbsp;</o:p></p><p class=MsoNormal><o:p>&nbsp;</o:p></p></div></body></html>
    We are trying to migrate to a better program to send marketing (using our mailserver), and we have PHPlist (server-side SMTP software) working great, however the identical message/subject/sender is going into the Junk box:
    Code:
    <html><head>
            <meta content="text/html;charset=UTF-8"
    http-equiv="Content-Type">
            <title></title>
    </head><body><p>Maricela,</p>
    <p>Current and hopeful competitors selling  medical products
    in Mexico will benefit from <strong>a complete roadmap and 
    essential data</strong> as provided in our newest report:
    &nbsp;Medical  Device Market Opportunities in Mexico,
    2012.</p>
    <p><a
    href="http://www.lifescienceintelligence.com/click/click.php?p=market-creports-page.php?id=LSI-OUS124SU&amp;e=maricela@lifescienceintelligence.com&amp;i=1&amp;n=Maricela">Medical
     Device Market Opportunities in Mexico, 2012</a>, from our
    extensive <a
    href="http://www.lifescienceintelligence.com/click/click.php?p=market-reports-index.php&amp;e=maricela@lifescienceintelligence.com&amp;i=1&amp;n=Maricela">Library
     of Reports</a>, quantifies, analyzes, and forecasts the
    trends and  opportunities in the medical devices market in
    Mexico.  &nbsp;Historical data covers 2007-2010; the most
    recent actual year data  is for 2011; and forecasts extend
    through 2014.</p>
    <p><strong>Questions Answered in This Report:</strong></p>
    <ul>
        <li>What are the key population, economic and 
    healthcare data and trends that a medical device
    manufacturer needs to know to  be competitive in
    Mexico?</li>
        <li>What are the disease incidence &amp; prevalence 
    data? What are the future trends? What do current and
    emerging patient  caseloads look like? Where are the
    opportunities?</li>
        <li>Procedure volumes and growth differ dramatically 
    within the different therapeutic areas in Mexico. What is
    the volume of  surgical procedures currently being performed
    in each therapeutic area? What  are the growth trends? Where
    are the procedures being performed?</li>
        <li>What is the regulatory path for getting a  medical
    device approved in Mexico? What other market barriers or
    challenges  exist?</li>
        <li>How does a medical product company access this 
    market? What are the sales models -- distributor, direct
    sales force, hybrid,  other?</li>
        <li>What other challenges and opportunities exist in 
    Mexico for current and hopeful market participants?</li>
    </ul>
    <p><strong>Essential Data:</strong></p>
    <ul>
        <li>Key Population Data, Trends, Indicators</li>
        <li>Key Economic Data, Trends, Indicators</li>
        <li>Key Healthcare Data, Trends, Indicators</li>
        <li>Clinical Indicators &amp; Statistics, by
    Segment</li>
        <li>Disease Incidence &amp; Prevalence Statistics,  by
    Segment</li>
        <li>Barriers to Entry for Medical Product Companies</li>
        <li>Regulatory Overview, Challenges and Path</li>
        <li>Channel Analysis &amp; Potential Sales Models 
    (Distributor, Direct, Hybrid, Other)</li>
        <li>Emerging Trends, Opportunities, and Market 
    Outlook</li>
        <li>Surgical Procedure Volumes, by Segment</li>
    </ul>
    <p>&nbsp;</p>
    <p>If you have any questions or would  like to place an
    order, feel free to order online, reply to this e-mail, or 
    give me a call.</p>
    <p>Regards,</p>
    <p>Brad</p>
    <p>Brad Shwam<br />
    Director of Sales<br />
    Life Science Intelligence (LSI)<br />
    Tel: &nbsp;1-714-847-3540, ext. 26<br />
    <a
    href="mailto:brad@LifeScienceIntelligence.com">brad@LifeScienceIntelligence.com</a><br
    />
    <a
    href="http://www.lifescienceintelligence.com/click/click.php?p=index.php&amp;e=maricela@lifescienceintelligence.com&amp;i=1&amp;n=Maricela">www.LifeScienceIntelligence.com</a></p>
    <p>To ensure delivery of our  updates to your inbox, please
    add @LifeScienceIntelligence.com to your address  book,
    contact list, or Safe Senders list.</p>
    <p>If you do not want to receive  these updates from us,
    simply reply with &quot;REMOVE&quot; in the subject 
    line.</p>
    <p>&copy; Copyright 2012 by Life Science  Intelligence.
    &nbsp;All rights reserved.</p>
    <p>Life Science Intelligence (LSI) <br />
    7372 Prince Drive, Suite 208<br />
    Huntington Beach, CA 92647<br />
    USA<br />
    Tel: 1-714-847-3540</p><br /><br /><div class="emailfooter">
    </div></body></html>
    Any idea why the first message sent from Outlook is going into our co-workers inbox but the second message sent from PHPlist with clean html is not (Same sender, same subject, etc)? PS- please dont suggest Constant Contact, Mail Chimp, Vertical Response, etc. It would be really helpful if you had any suggestions on why the near-identical message is not getting through to the Inbox.

  6. #6
    Foozle Reducer ServerStorm's Avatar
    Join Date
    Feb 2005
    Location
    Burlington, Canada
    Posts
    2,699
    Mentioned
    89 Post(s)
    Tagged
    6 Thread(s)
    Quote Originally Posted by ripcurlksm View Post
    Steve, thank you for taking the time to check out my site. All this is being prompted from a co-worker that we are using as a test case for marketing. They have their junk email filter set to "High".

    If we send them a message from Outlook with a subject line it goes to the Inbox and the "view source" of the email looks like this:
    Code:
    <html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40"><head><META HTTP-EQUIV="Content-Type" CONTENT="text/html; charset=us-ascii"><meta name=Generator content="Microsoft Word 12 (filtered medium)"><!--[if !mso]><style>v\:* {behavior:url(#default#VML);}
    o\:* {behavior:url(#default#VML);}
    w\:* {behavior:url(#default#VML);}
    .shape {behavior:url(#default#VML);}
    </style><![endif]--><style><!--
    /* Font Definitions */
    @font-face
        {font-family:"Cambria Math";
        panose-1:2 4 5 3 5 4 6 3 2 4;}
    @font-face
        {font-family:Calibri;
        panose-1:2 15 5 2 2 2 4 3 2 4;}
    @font-face
        {font-family:Tahoma;
        panose-1:2 11 6 4 3 5 4 4 2 4;}
    /* Style Definitions */
    p.MsoNormal, li.MsoNormal, div.MsoNormal
        {margin:0in;
        margin-bottom:.0001pt;
        font-size:11.0pt;
        font-family:"Calibri","sans-serif";}
    a:link, span.MsoHyperlink
        {mso-style-priority:99;
        color:blue;
        text-decoration:underline;}
    a:visited, span.MsoHyperlinkFollowed
        {mso-style-priority:99;
        color:purple;
        text-decoration:underline;}
    p
        {mso-style-priority:99;
        mso-margin-top-alt:auto;
        margin-right:0in;
        mso-margin-bottom-alt:auto;
        margin-left:0in;
        font-size:12.0pt;
        font-family:"Times New Roman","serif";}
    p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
        {mso-style-priority:99;
        mso-style-link:"Balloon Text Char";
        margin:0in;
        margin-bottom:.0001pt;
        font-size:8.0pt;
        font-family:"Tahoma","sans-serif";}
    p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph
        {mso-style-priority:34;
        margin-top:0in;
        margin-right:0in;
        margin-bottom:0in;
        margin-left:.5in;
        margin-bottom:.0001pt;
        font-size:11.0pt;
        font-family:"Calibri","sans-serif";}
    span.EmailStyle17
        {mso-style-type:personal-compose;
        font-family:"Calibri","sans-serif";
        color:windowtext;}
    span.apple-converted-space
        {mso-style-name:apple-converted-space;}
    span.BalloonTextChar
        {mso-style-name:"Balloon Text Char";
        mso-style-priority:99;
        mso-style-link:"Balloon Text";
        font-family:"Tahoma","sans-serif";}
    .MsoChpDefault
        {mso-style-type:export-only;}
    @page WordSection1
        {size:8.5in 11.0in;
        margin:1.0in 1.0in 1.0in 1.0in;}
    div.WordSection1
        {page:WordSection1;}
    /* List Definitions */
    @list l0
        {mso-list-id:496192127;
        mso-list-type:hybrid;
        mso-list-template-ids:1887317496 67698689 67698691 67698693 67698689 67698691 67698693 67698689 67698691 67698693;}
    @list l0:level1
        {mso-level-number-format:bullet;
        mso-level-text:\F0B7;
        mso-level-tab-stop:none;
        mso-level-number-position:left;
        text-indent:-.25in;
        font-family:Symbol;}
    @list l0:level2
        {mso-level-tab-stop:1.0in;
        mso-level-number-position:left;
        text-indent:-.25in;}
    @list l0:level3
        {mso-level-tab-stop:1.5in;
        mso-level-number-position:left;
        text-indent:-.25in;}
    @list l0:level4
        {mso-level-tab-stop:2.0in;
        mso-level-number-position:left;
        text-indent:-.25in;}
    @list l0:level5
        {mso-level-tab-stop:2.5in;
        mso-level-number-position:left;
        text-indent:-.25in;}
    @list l0:level6
        {mso-level-tab-stop:3.0in;
        mso-level-number-position:left;
        text-indent:-.25in;}
    @list l0:level7
        {mso-level-tab-stop:3.5in;
        mso-level-number-position:left;
        text-indent:-.25in;}
    @list l0:level8
        {mso-level-tab-stop:4.0in;
        mso-level-number-position:left;
        text-indent:-.25in;}
    @list l0:level9
        {mso-level-tab-stop:4.5in;
        mso-level-number-position:left;
        text-indent:-.25in;}
    @list l1
        {mso-list-id:2097897314;
        mso-list-type:hybrid;
        mso-list-template-ids:-168770404 67698689 67698691 67698693 67698689 67698691 67698693 67698689 67698691 67698693;}
    @list l1:level1
        {mso-level-number-format:bullet;
        mso-level-text:\F0B7;
        mso-level-tab-stop:none;
        mso-level-number-position:left;
        text-indent:-.25in;
        font-family:Symbol;}
    @list l1:level2
        {mso-level-tab-stop:1.0in;
        mso-level-number-position:left;
        text-indent:-.25in;}
    @list l1:level3
        {mso-level-tab-stop:1.5in;
        mso-level-number-position:left;
        text-indent:-.25in;}
    @list l1:level4
        {mso-level-tab-stop:2.0in;
        mso-level-number-position:left;
        text-indent:-.25in;}
    @list l1:level5
        {mso-level-tab-stop:2.5in;
        mso-level-number-position:left;
        text-indent:-.25in;}
    @list l1:level6
        {mso-level-tab-stop:3.0in;
        mso-level-number-position:left;
        text-indent:-.25in;}
    @list l1:level7
        {mso-level-tab-stop:3.5in;
        mso-level-number-position:left;
        text-indent:-.25in;}
    @list l1:level8
        {mso-level-tab-stop:4.0in;
        mso-level-number-position:left;
        text-indent:-.25in;}
    @list l1:level9
        {mso-level-tab-stop:4.5in;
        mso-level-number-position:left;
        text-indent:-.25in;}
    ol
        {margin-bottom:0in;}
    ul
        {margin-bottom:0in;}
    --></style><!--[if gte mso 9]><xml>
    <o:shapedefaults v:ext="edit" spidmax="2050" />
    </xml><![endif]--><!--[if gte mso 9]><xml>
    <o:shapelayout v:ext="edit">
    <o:idmap v:ext="edit" data="1" />
    </o:shapelayout></xml><![endif]--></head><body lang=EN-US link=blue vlink=purple><div class=WordSection1><p class=MsoNormal><o:p>&nbsp;</o:p></p><p class=MsoNormal><img width=264 height=67 id="Picture_x0020_1" src="cid:image001.gif@01CDBB50.A40B3C70" alt="cid:image001.gif@01CDA7BC.8946A110"><o:p></o:p></p><p class=MsoNormal><o:p>&nbsp;</o:p></p><p class=MsoNormal>Bernadette,<o:p></o:p></p><p class=MsoNormal><o:p>&nbsp;</o:p></p><p style='margin:0in;margin-bottom:.0001pt'><span style='font-size:11.0pt;font-family:"Calibri","sans-serif"'>Current and hopeful competitors selling medical products in Mexico will benefit from <b>a complete roadmap and essential data</b> as provided in our newest report:<span style='color:black'> </span>&nbsp;Medical Device Market Opportunities in Mexico, 2012.<o:p></o:p></span></p><p style='margin:0in;margin-bottom:.0001pt'><span style='font-size:11.0pt;font-family:"Calibri","sans-serif"'><o:p>&nbsp;</o:p></span></p><p style='margin:0in;margin-bottom:.0001pt'><span style='font-size:11.0pt;font-family:"Calibri","sans-serif"'><a href="http://www.lifescienceintelligence.com/click/click.php?p=market-creports-page.php?id=LSI-OUS124SU&amp;e=bsilva@lifescienceintelligence.com&amp;i=1&amp;n=Bernadette">Medical Device Market Opportunities in Mexico, 2012</a>, from our extensive <a href="http://lifescienceintelligence.com/click/click.php?p=market-reports-index.php&amp;e=bsilva@lifescienceintelligence.com&amp;i=1&amp;n=Bernadette">Library of Reports</a>, quantifies, analyzes, and forecasts the trends and opportunities in the medical devices market in Mexico.<span style='color:black'> </span>&nbsp;Historical data covers 2007-2010; the most recent actual year data is for 2011; and forecasts extend through 2014.<o:p></o:p></span></p><p style='margin:0in;margin-bottom:.0001pt'><strong><o:p>&nbsp;</o:p></strong></p><p class=MsoNormal><b>Questions Answered in This Report:</b><o:p></o:p></p><p class=MsoListParagraph style='text-indent:-.25in;mso-list:l1 level1 lfo1'><![if !supportLists]><span style='font-family:Symbol'><span style='mso-list:Ignore'>&middot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><![endif]>What are the key population, economic and healthcare data and trends that a medical device manufacturer needs to know to be competitive in Mexico?<o:p></o:p></p><p class=MsoListParagraph style='text-indent:-.25in;mso-list:l1 level1 lfo1'><![if !supportLists]><span style='font-family:Symbol'><span style='mso-list:Ignore'>&middot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><![endif]>What are the disease incidence &amp; prevalence data? What are the future trends? What do current and emerging patient caseloads look like? Where are the opportunities?<o:p></o:p></p><p class=MsoListParagraph style='text-indent:-.25in;mso-list:l1 level1 lfo1'><![if !supportLists]><span style='font-family:Symbol'><span style='mso-list:Ignore'>&middot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><![endif]>Procedure volumes and growth differ dramatically within the different therapeutic areas in Mexico. What is the volume of surgical procedures currently being performed in each therapeutic area? What are the growth trends? Where are the procedures being performed?<o:p></o:p></p><p class=MsoListParagraph style='text-indent:-.25in;mso-list:l1 level1 lfo1'><![if !supportLists]><span style='font-family:Symbol'><span style='mso-list:Ignore'>&middot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><![endif]>What is the regulatory path for getting a medical device approved in Mexico? What other market barriers or challenges exist?<o:p></o:p></p><p class=MsoListParagraph style='text-indent:-.25in;mso-list:l1 level1 lfo1'><![if !supportLists]><span style='font-family:Symbol'><span style='mso-list:Ignore'>&middot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><![endif]>How does a medical product company access this market? What are the sales models -- distributor, direct sales force, hybrid, other?<o:p></o:p></p><p class=MsoListParagraph style='text-indent:-.25in;mso-list:l1 level1 lfo1'><![if !supportLists]><span style='font-family:Symbol'><span style='mso-list:Ignore'>&middot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><![endif]>What other challenges and opportunities exist in Mexico for current and hopeful market participants?<o:p></o:p></p><p class=MsoNormal><o:p>&nbsp;</o:p></p><p class=MsoNormal><b>Essential Data:<o:p></o:p></b></p><p class=MsoListParagraph style='text-indent:-.25in;mso-list:l0 level1 lfo2'><![if !supportLists]><span style='font-family:Symbol'><span style='mso-list:Ignore'>&middot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><![endif]>Key Population Data, Trends, Indicators <o:p></o:p></p><p class=MsoListParagraph style='text-indent:-.25in;mso-list:l0 level1 lfo2'><![if !supportLists]><span style='font-family:Symbol'><span style='mso-list:Ignore'>&middot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><![endif]>Key Economic Data, Trends, Indicators <o:p></o:p></p><p class=MsoListParagraph style='text-indent:-.25in;mso-list:l0 level1 lfo2'><![if !supportLists]><span style='font-family:Symbol'><span style='mso-list:Ignore'>&middot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><![endif]>Key Healthcare Data, Trends, Indicators <o:p></o:p></p><p class=MsoListParagraph style='text-indent:-.25in;mso-list:l0 level1 lfo2'><![if !supportLists]><span style='font-family:Symbol'><span style='mso-list:Ignore'>&middot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><![endif]>Clinical Indicators &amp; Statistics, by Segment <o:p></o:p></p><p class=MsoListParagraph style='text-indent:-.25in;mso-list:l0 level1 lfo2'><![if !supportLists]><span style='font-family:Symbol'><span style='mso-list:Ignore'>&middot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><![endif]>Disease Incidence &amp; Prevalence Statistics, by Segment <o:p></o:p></p><p class=MsoListParagraph style='text-indent:-.25in;mso-list:l0 level1 lfo2'><![if !supportLists]><span style='font-family:Symbol'><span style='mso-list:Ignore'>&middot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><![endif]>Barriers to Entry for Medical Product Companies<o:p></o:p></p><p class=MsoListParagraph style='text-indent:-.25in;mso-list:l0 level1 lfo2'><![if !supportLists]><span style='font-family:Symbol'><span style='mso-list:Ignore'>&middot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><![endif]>Regulatory Overview, Challenges and Path<o:p></o:p></p><p class=MsoListParagraph style='text-indent:-.25in;mso-list:l0 level1 lfo2'><![if !supportLists]><span style='font-family:Symbol'><span style='mso-list:Ignore'>&middot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><![endif]>Channel Analysis &amp; Potential Sales Models (Distributor, Direct, Hybrid, Other)<o:p></o:p></p><p class=MsoListParagraph style='text-indent:-.25in;mso-list:l0 level1 lfo2'><![if !supportLists]><span style='font-family:Symbol'><span style='mso-list:Ignore'>&middot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><![endif]>Emerging Trends, Opportunities, and Market Outlook <o:p></o:p></p><p class=MsoListParagraph style='text-indent:-.25in;mso-list:l0 level1 lfo2'><![if !supportLists]><span style='font-family:Symbol'><span style='mso-list:Ignore'>&middot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><![endif]>Surgical Procedure Volumes, by Segment <o:p></o:p></p><p class=MsoNormal><o:p>&nbsp;</o:p></p><p class=MsoNormal>Additional Opportunity Reports are available:<span style='color:black'> </span>&nbsp;<span style='color:blue'><a href="http://lifescienceintelligence.com/click/click.php?p=market-creports-page.php?id=LSI-OUS121SU&amp;e=bsilva@lifescienceintelligence.com&amp;i=1&amp;n=Bernadette"><span style='text-decoration:none'>Brazil</span></a></span><span style='color:black;background:white'>,<span class=apple-converted-space> </span></span><span style='color:blue'><a href="http://lifescienceintelligence.com/click/click.php?p=market-creports-page.php?id=LSI-OUS125SU&amp;e=bsilva@lifescienceintelligence.com&amp;i=1&amp;n=Bernadette"><span style='text-decoration:none'>Russia</span></a></span><span style='color:black;background:white'>,<span class=apple-converted-space> </span></span><span style='color:blue'><a href="http://lifescienceintelligence.com/click/click.php?p=market-creports-page.php?id=LSI-OUS122SU&amp;e=bsilva@lifescienceintelligence.com&amp;i=1&amp;n=Bernadette"><span style='text-decoration:none'>India</span></a></span><span style='color:black;background:white'>,<span class=apple-converted-space> </span></span><span style='color:blue'><a href="http://lifescienceintelligence.com/click/click.php?p=market-creports-page.php?id=LSI-OUS123SU&amp;e=bsilva@lifescienceintelligence.com&amp;i=1&amp;n=Bernadette"><span style='text-decoration:none'>China</span></a></span><span style='color:black;background:white'>,<span class=apple-converted-space> </span></span><span style='color:blue'><a href="http://lifescienceintelligence.com/click/click.php?p=market-creports-page.php?id=LSI-OUS126SU&amp;e=bsilva@lifescienceintelligence.com&amp;i=1&amp;n=Bernadette"><span style='text-decoration:none'>France</span></a></span><span style='color:black;background:white'>,<span class=apple-converted-space> </span></span><span style='color:blue'><a href="http://lifescienceintelligence.com/click/click.php?p=market-creports-page.php?id=LSI-OUS127SU&amp;e=bsilva@lifescienceintelligence.com&amp;i=1&amp;n=Bernadette"><span style='text-decoration:none'>Germany</span></a></span><span style='color:black;background:white'>,<span class=apple-converted-space> </span></span><span style='color:blue'><a href="http://lifescienceintelligence.com/click/click.php?p=market-creports-page.php?id=LSI-OUS128SU&amp;e=bsilva@lifescienceintelligence.com&amp;i=1&amp;n=Bernadette"><span style='text-decoration:none'>Italy</span></a></span><span style='color:black;background:white'>, the<span class=apple-converted-space> </span></span><span style='color:blue'><a href="http://lifescienceintelligence.com/click/click.php?p=market-creports-page.php?id=LSI-OUS129SU&amp;e=bsilva@lifescienceintelligence.com&amp;i=1&amp;n=Bernadette"><span style='text-decoration:none'>United Kingdom</span></a></span><span style='color:black;background:white'>, and<span class=apple-converted-space> </span></span><span style='color:blue'><a href="http://lifescienceintelligence.com/click/click.php?p=market-creports-page.php?id=LSI-OUS1210SU&amp;e=bsilva@lifescienceintelligence.com&amp;i=1&amp;n=Bernadette"><span style='text-decoration:none'>Spain</span></a></span>.<o:p></o:p></p><p class=MsoNormal><span style='color:black'><o:p>&nbsp;</o:p></span></p><p class=MsoNormal><span style='color:black'>If you have any questions or would like to place an order, feel free to order online, reply to this e-mail, or give me a call.<o:p></o:p></span></p><p class=MsoNormal><span style='color:black'><o:p>&nbsp;</o:p></span></p><p class=MsoNormal>Regards,<span style='color:black'> <o:p></o:p></span></p><p class=MsoNormal><span style='color:black'><o:p>&nbsp;</o:p></span></p><p class=MsoNormal><span style='color:black'>Brad<o:p></o:p></span></p><p class=MsoNormal><span style='color:black'><o:p>&nbsp;</o:p></span></p><p class=MsoNormal><span style='color:black'>Brad Shwam<o:p></o:p></span></p><p class=MsoNormal><span style='color:black'>Director of Sales<o:p></o:p></span></p><p class=MsoNormal><span style='color:black'>Life Science Intelligence (LSI)<o:p></o:p></span></p><p class=MsoNormal><span style='color:black'>Tel: &nbsp;1-714-847-3540, ext. 26<o:p></o:p></span></p><p class=MsoNormal><span style='color:black'><a href="mailto:brad@LifeScienceIntelligence.com">brad@LifeScienceIntelligence.com</a><o:p></o:p></span></p><p class=MsoNormal><span style='color:blue'><a href="http://www.lifescienceintelligence.com/">www.LifeScienceIntelligence.com</a><o:p></o:p></span></p><p class=MsoNormal><span style='color:blue'><o:p>&nbsp;</o:p></span></p><p style='margin:0in;margin-bottom:.0001pt'><span style='font-size:11.0pt;font-family:"Calibri","sans-serif";color:black'>To ensure delivery of our updates to your inbox, please add @LifeScienceIntelligence.com to your address book, contact list, or Safe Senders list.<o:p></o:p></span></p><p style='margin:0in;margin-bottom:.0001pt'><span style='font-size:11.0pt;font-family:"Calibri","sans-serif";color:black'><o:p>&nbsp;</o:p></span></p><p style='margin:0in;margin-bottom:.0001pt'><span style='font-size:11.0pt;font-family:"Calibri","sans-serif";color:black'>If you do not want to receive these updates from us, simply reply with &quot;REMOVE&quot; in the subject line.<o:p></o:p></span></p><p class=MsoNormal><span style='color:black'><o:p>&nbsp;</o:p></span></p><p class=MsoNormal><span style='color:black'>&copy; Copyright 2012 by Life Science Intelligence. &nbsp;All rights reserved.<o:p></o:p></span></p><p class=MsoNormal><span style='color:black'><o:p>&nbsp;</o:p></span></p><p style='margin:0in;margin-bottom:.0001pt'><span style='font-size:11.0pt;font-family:"Calibri","sans-serif";color:black'>Life Science Intelligence (LSI)</span><span style='font-size:11.0pt;font-family:"Calibri","sans-serif"'><o:p></o:p></span></p><p class=MsoNormal><span style='color:black'>7372 Prince Drive, Suite 208</span><o:p></o:p></p><p class=MsoNormal><span style='color:black'>Huntington Beach, CA 92647<o:p></o:p></span></p><p class=MsoNormal><span style='color:black'>USA</span><o:p></o:p></p><p class=MsoNormal><span style='color:black'>Tel: 1-714-847-3540<o:p></o:p></span></p><p class=MsoNormal><o:p>&nbsp;</o:p></p><p class=MsoNormal><o:p>&nbsp;</o:p></p><p class=MsoNormal><o:p>&nbsp;</o:p></p><p class=MsoNormal><o:p>&nbsp;</o:p></p></div></body></html>
    We are trying to migrate to a better program to send marketing (using our mailserver), and we have PHPlist (server-side SMTP software) working great, however the identical message/subject/sender is going into the Junk box:
    Code:
    <html><head>
            <meta content="text/html;charset=UTF-8"
    http-equiv="Content-Type">
            <title></title>
    </head><body><p>Maricela,</p>
    <p>Current and hopeful competitors selling  medical products
    in Mexico will benefit from <strong>a complete roadmap and 
    essential data</strong> as provided in our newest report:
    &nbsp;Medical  Device Market Opportunities in Mexico,
    2012.</p>
    <p><a
    href="http://www.lifescienceintelligence.com/click/click.php?p=market-creports-page.php?id=LSI-OUS124SU&amp;e=maricela@lifescienceintelligence.com&amp;i=1&amp;n=Maricela">Medical
     Device Market Opportunities in Mexico, 2012</a>, from our
    extensive <a
    href="http://www.lifescienceintelligence.com/click/click.php?p=market-reports-index.php&amp;e=maricela@lifescienceintelligence.com&amp;i=1&amp;n=Maricela">Library
     of Reports</a>, quantifies, analyzes, and forecasts the
    trends and  opportunities in the medical devices market in
    Mexico.  &nbsp;Historical data covers 2007-2010; the most
    recent actual year data  is for 2011; and forecasts extend
    through 2014.</p>
    <p><strong>Questions Answered in This Report:</strong></p>
    <ul>
        <li>What are the key population, economic and 
    healthcare data and trends that a medical device
    manufacturer needs to know to  be competitive in
    Mexico?</li>
        <li>What are the disease incidence &amp; prevalence 
    data? What are the future trends? What do current and
    emerging patient  caseloads look like? Where are the
    opportunities?</li>
        <li>Procedure volumes and growth differ dramatically 
    within the different therapeutic areas in Mexico. What is
    the volume of  surgical procedures currently being performed
    in each therapeutic area? What  are the growth trends? Where
    are the procedures being performed?</li>
        <li>What is the regulatory path for getting a  medical
    device approved in Mexico? What other market barriers or
    challenges  exist?</li>
        <li>How does a medical product company access this 
    market? What are the sales models -- distributor, direct
    sales force, hybrid,  other?</li>
        <li>What other challenges and opportunities exist in 
    Mexico for current and hopeful market participants?</li>
    </ul>
    <p><strong>Essential Data:</strong></p>
    <ul>
        <li>Key Population Data, Trends, Indicators</li>
        <li>Key Economic Data, Trends, Indicators</li>
        <li>Key Healthcare Data, Trends, Indicators</li>
        <li>Clinical Indicators &amp; Statistics, by
    Segment</li>
        <li>Disease Incidence &amp; Prevalence Statistics,  by
    Segment</li>
        <li>Barriers to Entry for Medical Product Companies</li>
        <li>Regulatory Overview, Challenges and Path</li>
        <li>Channel Analysis &amp; Potential Sales Models 
    (Distributor, Direct, Hybrid, Other)</li>
        <li>Emerging Trends, Opportunities, and Market 
    Outlook</li>
        <li>Surgical Procedure Volumes, by Segment</li>
    </ul>
    <p>&nbsp;</p>
    <p>If you have any questions or would  like to place an
    order, feel free to order online, reply to this e-mail, or 
    give me a call.</p>
    <p>Regards,</p>
    <p>Brad</p>
    <p>Brad Shwam<br />
    Director of Sales<br />
    Life Science Intelligence (LSI)<br />
    Tel: &nbsp;1-714-847-3540, ext. 26<br />
    <a
    href="mailto:brad@LifeScienceIntelligence.com">brad@LifeScienceIntelligence.com</a><br
    />
    <a
    href="http://www.lifescienceintelligence.com/click/click.php?p=index.php&amp;e=maricela@lifescienceintelligence.com&amp;i=1&amp;n=Maricela">www.LifeScienceIntelligence.com</a></p>
    <p>To ensure delivery of our  updates to your inbox, please
    add @LifeScienceIntelligence.com to your address  book,
    contact list, or Safe Senders list.</p>
    <p>If you do not want to receive  these updates from us,
    simply reply with &quot;REMOVE&quot; in the subject 
    line.</p>
    <p>&copy; Copyright 2012 by Life Science  Intelligence.
    &nbsp;All rights reserved.</p>
    <p>Life Science Intelligence (LSI) <br />
    7372 Prince Drive, Suite 208<br />
    Huntington Beach, CA 92647<br />
    USA<br />
    Tel: 1-714-847-3540</p><br /><br /><div class="emailfooter">
    </div></body></html>
    Any idea why the first message sent from Outlook is going into our co-workers inbox but the second message sent from PHPlist with clean html is not (Same sender, same subject, etc)? PS- please dont suggest Constant Contact, Mail Chimp, Vertical Response, etc. It would be really helpful if you had any suggestions on why the near-identical message is not getting through to the Inbox.
    It may not have anything to do with your HTML (unless the SPAM filter is catching the &nbsp; ). It may be that your PHPlist is not contacting the mail server properly. You need to make sure:
    • Must say Helo with the canonical host name that is the same as the host name
    • Your forward and reverse mail pointers need to match
    • Need to ensure it is not an open relay


    I would highly recommend looking at swiftmailer.org. I don't work for them, however I use it and can atest to the fact that it creates RFC compliant email, gives you advanced scheduling features and throttling, and it is regularly updated.

    Steve
    ictus==""


Bookmarks

Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts
  •